Dietary L-Tyrosine supplementation in nemaline myopathy

Journal of Child Neurology

Volumn 23, Issue 6, 2008, Pages 609-613

  Ryan, Monique M ^a,b   Sy, Catherine ^c   Rudge, Sian ^c   Ellaway, Carolyn ^c   Ketteridge, David ^d   Roddick, Laurence G ^e   Iannaccone, Susan T ^f   Kornberg, Andrew J ^a,b   North, Kathryn N ^c,g  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

^f TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Myopathy; Nemaline; Sialorrhoea; Tyrosine

Indexed keywords

ALPHA TROPOMYOSIN; ARGININE; BOTULINUM TOXIN; METHIONINE; TYROSINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BULBAR PARALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIET SUPPLEMENTATION; DRUG DOSE INCREASE; EXERCISE TOLERANCE; FAILURE TO THRIVE; FEEDING BEHAVIOR; HUMAN; HUMAN TISSUE; HYPERSALIVATION; INFANT; LUNG INSUFFICIENCY; MISSENSE MUTATION; MOTOR DYSFUNCTION; MUSCLE BIOPSY; MUSCLE HYPOTONIA; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEMALINE MYOPATHY; NEUROLOGIC EXAMINATION; NOSE FEEDING; PRIORITY JOURNAL; TACHYPNEA;

ADOLESCENT; APPETITE; BIOPSY; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROSCOPY, ELECTRON; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUTATION, MISSENSE; MYOPATHIES, NEMALINE; PHENOTYPE; SIALORRHEA; TREATMENT OUTCOME; TROPOMYOSIN; TYROSINE; WEIGHT GAIN;

EID: 44149126988     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807309794     Document Type: Article

References (19)

1. Ryan MM, Schnell C., Strickland CD, Shield LK, Morgan G., Iannaccone ST, Laing NG, Beggs AH, North KN Nemaline myopathy: A clinical study of 143 cases. Ann Neurol. 2001;50:312-320.
2. Scriver CR, Beaudet AL, Sly WS, Valle D., Childs B., Kinzler KW, Vogelstein B. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001.
3. Kalita D. A new treatment for congenital nonprogressive nemaline myopathy. J Orthomol Med. 1989;2:70-74.
4. Wallgren-Pettersson C., Laing NG 109th ENMC International Workshop: 5th workshop on nemaline myopathy, 11th-13th October 2002, Naarden, The Netherlands. Neuromusc Disord. 2003;13:501-507.
5. Laing NG, Wilton SD, Akkari PA, Dorosz S., Boundy K., Kneebone C., Blumbergs P., White S., Watkins H., Love DR, Haan E. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet. 1995;9:75-79.
6. Her Majesty's Stationery Office. Aids to the Examination of the Peripheral Nervous System. London: Medical Research Council Memorandum no 45;1976.
7. Vignos PJ, Spencer GE, Archibald KC Management of progressive muscular dystrophy of childhood. JAMA. 1963;184:89-96.
8. Ellaway C. The symptom severity index. In: Rett Syndrome: Diagnostic Strategies and Therapeutic Intervention [dissertation]. University of Sydney; 2000.
9. Reilly S., Skuse D., Wolke D. SOMA: Schedule For Oral Motor Assessment. Eastgardens, Australia: Whurr; 2000.
10. Brei TJ Management of drooling. Semin Pediatr Neurol. 2003;10:265-270.
11. Dodd J., Role LW The sympathetic nervous system. In: Kandel ER, Schwartz JH, Jessel TM, eds. Principles of Neural Science. 3rd ed. London: Appleton and Lange; 1991:761-777.
12. Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC, Fung VS, Earl J., Wilcken B. Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy. Mov Disord. 2002;17:354-359.
13. Growdon JH, Melamed E., Logu M., Hefti F., Wurtman RJ Effects of oral tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 1982;30:827-832.
14. Kalsner LR, Rohr FJ, Strauss KA, Korson MS, Levy HL Tyrosine supplementation in phenylketonuria: Diurnal blood tyrosine levels and presumptive brain influx of tyrosine and other large neutral amino acids. J Pediatr. 2001;139:421-427.
15. Agharanya JC, Alonso R., Wurtman RJ Changes in catecholamine excretion after short-term tyrosine ingestion in normally fed human subjects. Am J Clin Nutr. 1981;34:82-87.
16. Nielsen JB, Lou HC, Andresen J. Biochemical and clinical effects of tyrosine and tryptophan in Rett syndrome. Brain Dev. 1990;12:143-147.
17. Mazzocco MM, Yannicelli S., Nord AM, van Doorninck W., Davidson-Mundt AJ, Greene CL Cognition and tyrosine supplementation among school-aged children with phenylketonuria. Am J Dis Child. 1992;146:1261-1264.
18. Lykkelund C., Nielsen JB, Rasmussen V., Rasmussen V., Gerdes AM, Christensen E., Guttler F. Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine. Eur J Pediatr. 1988;148:238-245.
19. Pietz J., Landwehr R., Kutscha A., Schmidt H., de Sonneville L., Trefz FK Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria. J Pediatr. 1995;127:936-943.